Supraventricular Tachycardia

advertisement
Paediatric Clinical Guidelines
Cardiology
2.1 Supraventricular Tachycardia
Short Title:
Supraventricular Tachycardia
Full Title:
Date of production/Last revision:
Guideline for the investigation and management of supraventricular
tachycardia in children and young people
August 2008
Explicit definition of patient group
to which it applies:
This guideline applies to all children and young people under the age of 19
years.
Name of contact author
Dr Muthu Dhanarass, Paediatric SpR
Dr Damian Wood, Consultant Paediatrician
Ext: 67319
August 2011
Revision Date
This guideline has been registered with the Trust. However, clinical guidelines are 'guidelines' only. The interpretation
and application of clinical guidelines will remain the responsibility of the individual clinician. If in doubt contact a
senior colleague or expert. Caution is advised when using guidelines after the review date.
Supraventricular Tachycardia
Please note there is a separate neonatal supraventricular tachycardia guideline for
infants less than 28 days of age.
Introduction


SVT is the commonest symptomatic arrhythmia in children
Typically
o The heart rate is usually above 200.
o 12 lead ECG shows a narrow complex, regular tachycardia.
o If present, p waves are seen for each QRS complex.
Assessment
History:
Infants – pallor, tachypnoea, poor feeding, irritability
Older children – palpitations, chest discomfort, dizziness
Often non-specific such as “feeling funny”
Examination:
Heart rate over 180 bpm (over 220/min in infants)
No beat to beat variation as in sinus tachycardia
Hypotension may be present
Heart failure (esp. in infants)
Investigations:
12 lead ECG if suspected
Urgent cardiology referral if tachycardia is broad complex
Or irregular
Other – if on medication, measure levels i.e. Digoxin,
Theophylline.
Management





Move to Resuscitation area when safe to do do
Assess ABC
Check BP and start continuous cardiac monitoring with paper recording
Oxygen Saturation.
12 lead ECG-Rhythm strip (P waves may not be visible)
Muthu Dhanarass
Page 1 of 3
October 2004
Paediatric Clinical Guidelines
Cardiology
2.1 Supraventricular Tachycardia
Algorithm for the Management of Supraventricular Tachycardia
If Shocked
1. Call for senior help,
2. Make sure airway equipment available
IF HAEMODYNAMICALLY STABLE – consider before drug treatment
1. Vagal manoeuvre
a. Bag of ice on face, Max. Duration 15 secs. (Ice cubes available in Children’s
Emergency Department Refrigerator )
b. Facial Immersion – wrap infant in towel, and immerse the whole head in iced
water for 5 seconds. No need to obstruct the mouth or nose.
c. Unilateral carotid massage
2. Valsalva in older children
DO NOT USE EYEBALL PRESSURE IN CASES OF SVT
IV Access – in large PROXIMAL vein preferably with a 3 way tap
Muthu Dhanarass
Page 2 of 3
October 2004
Paediatric Clinical Guidelines
Cardiology
2.1 Supraventricular Tachycardia
Adenosine






Prepare all doses of adenosine (as in algorithm) and 5ml saline flushes
Start with adenosine 100mcg/kg
Turn on ECG paper recorder
RAPIDLY administer adenosine as push, followed IMMEDIATELY by saline flush
If rhythm does not revert to Sinus rhythm, repeat Adenosine at increasing doses.
Maximum dose is 300mcg/kg (<1 month); 500mcg/kg (>1 month) up to maximum of 12
mg.
For adolescents adenosine doses can be rounded as 3mg followed by 6mg and then
12mg
Perform ECG post reversion
Adenosine side effects – flushing, nausea, chest tightness.
Caution should be taken if patients are on Dipyrimadole – it prolongs the action of the
adenosine. The dosage of adenosine should be reduced by a factor of 4.
IF THESE MEASURES FAIL, Contact the ON-CALL ACUTE PAEDIATRIC CONSULTANT
and discuss with Dr Thakker or Paediatric Cardiologist at Glenfield Hospital(0116 2871471)
and fax the ECG to cardiac centre
Other Drugs Used in the Treatment of SVT
One of the following drugs may be suggested. But many of them are unsafe to use in the
same patient. The patient can be treated by external cardioversion with a general
anaesthesia, but we strongly recommend discussion with the on call Paediatric
Cardiologist before administration of drugs other than Adenosine.
Give on PICU only, monitoring BP and ECG closely. Make sure defibrillator and pacemaker
facilities available.
Amiodarone:
Used in refractory atrial tachycardia, (Dose 5mg/kg over 30mins, Dilute in 4ml/kg of 5%
Dextrose)
Procainamide: Loading dose 15mg/kg over 30 to 60 mins with ECG and BP monitoring.
STOP if QRS complex widens in ECG or Blood pressure falls.
Flecainide
2mg/kg IV over 20 minutes
Particularly useful for WPW
STOP if new arrhythmias in ECG and changes in QRS.
Verapamil
Should not be given if
 <1 year of age (risk of irreversible hypotension, asystole)
 Beta-blocker (eg.propronolol) used within the last 24 hrs
 if there are signs of heart failure or poor LV function
Administer as slow IV
o Age 1-2 years, 100 to 200 mcg/kg (max 2g) over 3 mins
o Over 2 years 100 to 300 mcg/kg (max 5g)
STOP infusion if sinus rhythm achieved or BP drops greater than 10mmHg
Muthu Dhanarass
Page 3 of 3
October 2004
Download